Cha Biotech Acquires Patent Rights Related to Mesenchymal Stem Cells
[Asia Economy Reporter Minji Lee] Cha Biotech announced on the 8th that it has obtained patents for a medium for direct differentiation of mesenchymal stem cells derived from pluripotent stem cells, a method for producing mesenchymal stem cells using the medium, and the mesenchymal stem cells produced by the method.
Hot Picks Today
"Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- Bull Market End Signal? Securities Firm Warns: "Sell SK hynix 'At This Moment'"
- "Greater Impact on Women Than Men"... The 'Diet Trap' That Causes Sleepless Nights and Suffering
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
The company stated, "Through this invention, we have established a technical foundation for the manufacturing method of embryonic stem cell-based therapeutics and plan to utilize it to secure price competitiveness and technological competitiveness."
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
